---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-043558"
form_type: "8-K"
ticker: "IBO"
cik: "0001834105"
company_name: "IMPACT BIOMEDICAL INC."
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T06:17:06.137865+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Impact Biomedical furnishes investor presentation; no specific financial updates disclosed

## Summary
- COO Mark Suseck began delivering investor presentations on November 4, 2024.
- Presentation slide deck furnished as Exhibit 99.1; no new financial data or guidance in the filing.
- Company does not assume obligation to update the presentation information.
- No material operational metrics, revenue, or earnings figures provided in the 8-K.

## SEC filing metadata
- accession: 0001493152-24-043558
- form_type: 8-K
- ticker: IBO
- cik: 0001834105
- company_name: IMPACT BIOMEDICAL INC.
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834105/000149315224043558/0001493152-24-043558-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834105/000149315224043558/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-043558
- JSON: https://secwatch.observer/filing/0001493152-24-043558.json
- Plain text: https://secwatch.observer/filing/0001493152-24-043558.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.